Holdings
The Hartford Healthcare Fund
As of Jul 31, 2026, The Hartford Healthcare Fund reported 75 positions worth US$750M. Largest: Eli Lilly And Company, Johnson & Johnson and Merck & Company, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 80,883 | US$92.9M | −13,636 | Jul 31, 2026 |
| Johnson & Johnson | 203K | US$52.1M | +19,101 | Jul 31, 2026 |
| Merck & Company, Inc. | 356K | US$46.3M | −65,362 | Jul 31, 2026 |
| Unitedhealth Group Incorporated | 88,244 | US$36.6M | −20,768 | Jul 31, 2026 |
| Abbvie Inc. | 130K | US$32.5M | +23,108 | Jul 31, 2026 |
| Elevance Health, Inc. | 61,615 | US$23.2M | +21,754 | Jul 31, 2026 |
| Intuitive Surgical, Inc. | 62,861 | US$22.2M | +5,125 | Jul 31, 2026 |
| Cvs Health Corporation | 210K | US$21.9M | −3,284 | Jul 31, 2026 |
| Vertex Pharmaceuticals Incorporated | 42,701 | US$20.4M | +1,755 | Jul 31, 2026 |
| Danaher Corporation | 102K | US$19.9M | −7,473 | Jul 31, 2026 |